Dr. Steven A. Fischkoff on Access to TIL Treatment for Patients With Melanoma
March 14th 2016Fischkoff says the goal of Lion Biotechnologies is to utilize a central manufacturing facility where medical professionals can submit tumor samples of their patients, and received the proper TIL-based treatment back from the manufacturing facility.